{
  "DOI": "10.1186/s40246-024-00571-2",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-024-00571-2",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe integration of transcriptomic, proteomic, druggable genetic and metabolomic association studies facilitated a comprehensive investigation of molecular features and shared pathways for cancers’ development and progression.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eComprehensive approaches consisting of transcriptome-wide association studies (TWAS), proteome-wide association studies (PWAS), summary-data-based Mendelian randomization (SMR) and MR were performed to identify genes significantly associated with cancers. The results identified in above analyzes were subsequently involved in phenotype scanning and enrichment analyzes to explore the possible health effects and shared pathways. Additionally, we also conducted MR analysis   to investigate metabolic pathways related to cancers.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eTotally 24 genes (18 transcriptomic, 1 proteomic and 5 druggable genetic) showed significant associations with cancers risk. All genes identified in multiple methods were mainly enriched in nuclear factor erythroid 2-related factor 2 (NRF2) pathway. Additionally, biosynthesis of ubiquinol and urate were found to play an important role in gastrointestinal tumors.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eA set of putatively causal genes and pathways relevant to cancers were identified in this study, shedding light on the shared biological processes for tumorigenesis and providing compelling genetic evidence to prioritize anti-cancer drugs development.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "571"
  ],
  "article-number": "42",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "8 October 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "17 January 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "24 April 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Jin",
      "given": "Xin",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Mei",
      "given": "Yunyun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yang",
      "given": "Puyu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Runze",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Haifeng",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wu",
      "given": "Yibin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Miao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "He",
      "given": "Xigan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jiang",
      "given": "Ziting",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhu",
      "given": "Weiping",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Lu",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T07:01:42Z",
    "timestamp": 1713942102000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T07:07:46Z",
    "timestamp": 1713942466000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "81874056",
        "81874182"
      ],
      "doi-asserted-by": "crossref",
      "name": "National Natural Science Foundation of China"
    },
    {
      "award": [
        "22ZR1413300"
      ],
      "name": "Shanghai Natural Science Foundation Project"
    },
    {
      "award": [
        "2022YFE0125300"
      ],
      "name": "National Key Kesearch and Development Plan of the Ministry of Science and Technology"
    },
    {
      "award": [
        "202240240",
        "201940043"
      ],
      "name": "the Public Health Bureau Foundation of Shanghai"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        25
      ]
    ],
    "date-time": "2024-04-25T00:27:34Z",
    "timestamp": 1714004854333
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2024,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            24
          ]
        ],
        "date-time": "2024-04-24T00:00:00Z",
        "timestamp": 1713916800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            24
          ]
        ],
        "date-time": "2024-04-24T00:00:00Z",
        "timestamp": 1713916800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00571-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-024-00571-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00571-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.21660",
      "author": "H Sung",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "issue": "3",
      "journal-title": "CA Cancer J Clin",
      "key": "571_CR1",
      "unstructured": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.",
      "volume": "71",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jama.2020.1166",
      "author": "OJ Wouters",
      "doi-asserted-by": "publisher",
      "first-page": "844",
      "issue": "9",
      "journal-title": "JAMA",
      "key": "571_CR2",
      "unstructured": "Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA. 2020;323(9):844–53.",
      "volume": "323",
      "year": "2020"
    },
    {
      "DOI": "10.1038/d41573-019-00074-z",
      "author": "H Dowden",
      "doi-asserted-by": "publisher",
      "first-page": "495",
      "issue": "7",
      "journal-title": "Nat Rev Drug Discov",
      "key": "571_CR3",
      "unstructured": "Dowden H, Munro J. Trends in clinical success rates and therapeutic focus. Nat Rev Drug Discov. 2019;18(7):495–6.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrd.2016.184",
      "author": "RK Harrison",
      "doi-asserted-by": "publisher",
      "first-page": "817",
      "issue": "12",
      "journal-title": "Nat Rev Drug Discov",
      "key": "571_CR4",
      "unstructured": "Harrison RK. Phase II and phase III failures: 2013–2015. Nat Rev Drug Discov. 2016;15(12):817–8.",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41569-020-00493-1",
      "author": "MV Holmes",
      "doi-asserted-by": "publisher",
      "first-page": "435",
      "issue": "6",
      "journal-title": "Nat Rev Cardiol",
      "key": "571_CR5",
      "unstructured": "Holmes MV, Richardson TG, Ference BA, Davies NM, Davey Smith G. Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development. Nat Rev Cardiol. 2021;18(6):435–53.",
      "volume": "18",
      "year": "2021"
    },
    {
      "DOI": "10.1038/ng.3314",
      "author": "MR Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "856",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "571_CR6",
      "unstructured": "Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856–60.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrd4051",
      "author": "RM Plenge",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "issue": "8",
      "journal-title": "Nat Rev Drug Discov",
      "key": "571_CR7",
      "unstructured": "Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat Rev Drug Discov. 2013;12(8):581–94.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41576-021-00387-z",
      "author": "WR Reay",
      "doi-asserted-by": "publisher",
      "first-page": "658",
      "issue": "10",
      "journal-title": "Nat Rev Genet",
      "key": "571_CR8",
      "unstructured": "Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22(10):658–71.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMoa054013",
      "author": "JC Cohen",
      "doi-asserted-by": "publisher",
      "first-page": "1264",
      "issue": "12",
      "journal-title": "N Engl J Med",
      "key": "571_CR9",
      "unstructured": "Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354(12):1264–72.",
      "volume": "354",
      "year": "2006"
    },
    {
      "DOI": "10.3390/v2020574",
      "author": "L Lopalco",
      "doi-asserted-by": "publisher",
      "first-page": "574",
      "issue": "2",
      "journal-title": "Viruses",
      "key": "571_CR10",
      "unstructured": "Lopalco L. CCR5: from natural resistance to a new anti-HIV strategy. Viruses. 2010;2(2):574–600.",
      "volume": "2",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41591-021-01310-z",
      "author": "L Gaziano",
      "doi-asserted-by": "publisher",
      "first-page": "668",
      "issue": "4",
      "journal-title": "Nat Med",
      "key": "571_CR11",
      "unstructured": "Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med. 2021;27(4):668–76.",
      "volume": "27",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-022-05473-8",
      "author": "MI Kurki",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "issue": "7944",
      "journal-title": "Nature",
      "key": "571_CR12",
      "unstructured": "Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–18.",
      "volume": "613",
      "year": "2023"
    },
    {
      "DOI": "10.1038/ng.3506",
      "author": "A Gusev",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "571_CR13",
      "unstructured": "Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48(3):245–52.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ng.3538",
      "author": "Z Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "481",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "571_CR14",
      "unstructured": "Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481–7.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pgen.1004383",
      "author": "C Giambartolomei",
      "doi-asserted-by": "publisher",
      "first-page": "e1004383",
      "issue": "5",
      "journal-title": "PLoS Genet",
      "key": "571_CR15",
      "unstructured": "Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41588-022-01051-w",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "593",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "571_CR16",
      "unstructured": "Zhang J, Dutta D, Köttgen A, Tin A, Schlosser P, Grams ME, et al. Plasma proteome analyzes in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat Genet. 2022;54(5):593–602.",
      "volume": "54",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41588-021-00978-w",
      "author": "E Ferkingstad",
      "doi-asserted-by": "publisher",
      "first-page": "1712",
      "issue": "12",
      "journal-title": "Nat Genet",
      "key": "571_CR17",
      "unstructured": "Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712–21.",
      "volume": "53",
      "year": "2021"
    },
    {
      "DOI": "10.1126/scitranslmed.aag1166",
      "author": "C Finan",
      "doi-asserted-by": "publisher",
      "first-page": "383",
      "journal-title": "Sci Transl Med",
      "key": "571_CR18",
      "unstructured": "Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9:383.",
      "volume": "9",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41588-021-00992-y",
      "author": "EA Lopera-Maya",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "571_CR19",
      "unstructured": "Lopera-Maya EA, Kurilshikov A, van der Graaf A, Hu S, Andreu-Sánchez S, Chen L, et al. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch microbiome project. Nat Genet. 2022;54(2):143–51.",
      "volume": "54",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41467-019-09234-6",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1523",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "571_CR20",
      "unstructured": "Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nature10189",
      "author": "GM DeNicola",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "issue": "7354",
      "journal-title": "Nature",
      "key": "571_CR21",
      "unstructured": "DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475(7354):106–9.",
      "volume": "475",
      "year": "2011"
    },
    {
      "DOI": "10.1002/mc.22745",
      "author": "S Tao",
      "doi-asserted-by": "publisher",
      "first-page": "182",
      "issue": "2",
      "journal-title": "Mol Carcinog",
      "key": "571_CR22",
      "unstructured": "Tao S, Rojo de la Vega M, Chapman E, Ooi A, Zhang DD. The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Mol Carcinog. 2018;57(2):182–92.",
      "volume": "57",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cell.2011.02.013",
      "author": "D Hanahan",
      "doi-asserted-by": "publisher",
      "first-page": "646",
      "issue": "5",
      "journal-title": "Cell",
      "key": "571_CR23",
      "unstructured": "Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.",
      "volume": "144",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ccell.2018.03.022",
      "author": "M Rojo de la Vega",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "issue": "1",
      "journal-title": "Cancer Cell",
      "key": "571_CR24",
      "unstructured": "Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer. Cancer Cell. 2018;34(1):21–43.",
      "volume": "34",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41568-021-00378-6",
      "author": "I Martínez-Reyes",
      "doi-asserted-by": "publisher",
      "first-page": "669",
      "issue": "10",
      "journal-title": "Nat Rev Cancer",
      "key": "571_CR25",
      "unstructured": "Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669–80.",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-020-1943-3",
      "author": "LB Alexandrov",
      "doi-asserted-by": "publisher",
      "first-page": "94",
      "issue": "7793",
      "journal-title": "Nature",
      "key": "571_CR26",
      "unstructured": "Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578(7793):94–101.",
      "volume": "578",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41586-022-04398-6",
      "author": "EN Bergstrom",
      "doi-asserted-by": "publisher",
      "first-page": "510",
      "issue": "7897",
      "journal-title": "Nature",
      "key": "571_CR27",
      "unstructured": "Bergstrom EN, Luebeck J, Petljak M, Khandekar A, Barnes M, Zhang T, et al. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. Nature. 2022;602(7897):510–7.",
      "volume": "602",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-022-04972-y",
      "author": "M Petljak",
      "doi-asserted-by": "publisher",
      "first-page": "799",
      "issue": "7920",
      "journal-title": "Nature",
      "key": "571_CR28",
      "unstructured": "Petljak M, Dananberg A, Chu K, Bergstrom EN, Striepen J, von Morgen P, et al. Mechanisms of APOBEC3 mutagenesis in human cancer cells. Nature. 2022;607(7920):799–807.",
      "volume": "607",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-023-06303-1",
      "author": "H Isozaki",
      "doi-asserted-by": "publisher",
      "first-page": "393",
      "issue": "7973",
      "journal-title": "Nature",
      "key": "571_CR29",
      "unstructured": "Isozaki H, Sakhtemani R, Abbasi A, Nikpour N, Stanzione M, Oh S, et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature. 2023;620(7973):393–401.",
      "volume": "620",
      "year": "2023"
    },
    {
      "DOI": "10.1089/ars.2010.3586",
      "author": "E Lubos",
      "doi-asserted-by": "publisher",
      "first-page": "1957",
      "issue": "7",
      "journal-title": "Antioxid Redox Signal",
      "key": "571_CR30",
      "unstructured": "Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15(7):1957–97.",
      "volume": "15",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-010-0841-z",
      "author": "J Hu",
      "doi-asserted-by": "publisher",
      "first-page": "425",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "571_CR31",
      "unstructured": "Hu J, Zhou GW, Wang N, Wang YJ. GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;124(2):425–31.",
      "volume": "124",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s13277-013-1035-1",
      "author": "T Men",
      "doi-asserted-by": "publisher",
      "first-page": "269",
      "issue": "1",
      "journal-title": "Tumor Biol",
      "key": "571_CR32",
      "unstructured": "Men T, Zhang X, Yang J, Shen B, Li X, Chen D, et al. The rs1050450 C \u003e T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis. Tumor Biol. 2014;35(1):269–75.",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1177/0960327111411499",
      "author": "O Erdem",
      "doi-asserted-by": "publisher",
      "first-page": "24",
      "issue": "1",
      "journal-title": "Hum Exp Toxicol",
      "key": "571_CR33",
      "unstructured": "Erdem O, Eken A, Akay C, Arsova-Sarafinovska Z, Matevska N, Suturkova L, et al. Association of GPX1 polymorphism, GPX activity and prostate cancer risk. Hum Exp Toxicol. 2012;31(1):24–31.",
      "volume": "31",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.canlet.2006.05.006",
      "author": "O Raaschou-Nielsen",
      "doi-asserted-by": "publisher",
      "first-page": "293",
      "issue": "2",
      "journal-title": "Cancer Lett",
      "key": "571_CR34",
      "unstructured": "Raaschou-Nielsen O, Sørensen M, Hansen RD, Frederiksen K, Tjønneland A, Overvad K, et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett. 2007;247(2):293–300.",
      "volume": "247",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.canlet.2005.04.019",
      "author": "R Hansen",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "issue": "1",
      "journal-title": "Cancer Lett",
      "key": "571_CR35",
      "unstructured": "Hansen R, Saebø M, Skjelbred CF, Nexø BA, Hagen PC, Bock G, et al. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett. 2005;229(1):85–91.",
      "volume": "229",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-12-4499",
      "author": "H Satoh",
      "doi-asserted-by": "publisher",
      "first-page": "4158",
      "issue": "13",
      "journal-title": "Cancer Res",
      "key": "571_CR36",
      "unstructured": "Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res. 2013;73(13):4158–68.",
      "volume": "73",
      "year": "2013"
    },
    {
      "DOI": "10.1126/science.aaw5473",
      "author": "B Faubert",
      "doi-asserted-by": "publisher",
      "first-page": "6487",
      "journal-title": "Science",
      "key": "571_CR37",
      "unstructured": "Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:6487.",
      "volume": "368",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41586-020-2475-6",
      "author": "I Martínez-Reyes",
      "doi-asserted-by": "publisher",
      "first-page": "288",
      "issue": "7824",
      "journal-title": "Nature",
      "key": "571_CR38",
      "unstructured": "Martínez-Reyes I, Cardona LR, Kong H, Vasan K, McElroy GS, Werner M, et al. Mitochondrial ubiquinol oxidation is necessary for Tumor growth. Nature. 2020;585(7824):288–92.",
      "volume": "585",
      "year": "2020"
    },
    {
      "DOI": "10.1073/pnas.1003428107",
      "author": "F Weinberg",
      "doi-asserted-by": "publisher",
      "first-page": "8788",
      "issue": "19",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "571_CR39",
      "unstructured": "Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107(19):8788–93.",
      "volume": "107",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cmet.2014.12.003",
      "author": "AS Tan",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "issue": "1",
      "journal-title": "Cell Metab",
      "key": "571_CR40",
      "unstructured": "Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J, et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015;21(1):81–94.",
      "volume": "21",
      "year": "2015"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-024-00571-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Prioritization of therapeutic targets for cancers using integrative multi-omics analysis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}